Seroprevalence Study of Hepatitis A Virus in Fars Province, Southern Iran

Overview

Journal Hepat Mon

Publisher Brieflands

Specialty Gastroenterology

Date 2012 Jun 19

PMID 22706273

Citations 22

Authors

Seyed Alireza Taghavi

Mohammad Kazem Hosseini Asl

Mozaffar Talebzadeh

Ahad Eshraghian

Affiliations

Soon will be listed here.

Abstract

Background: There are several studies on seroprevalence of hepatitis A virus (HAV) in adults in the Middle East.

Objectives: To determine seroprevalence of HAV among adult population in Fars province, southern Iran.

Patients And Methods: In a cross-sectional study, we checked anti-HAV antibody (IgG) in subjects refereed to our health care centers to perform laboratory tests before getting married between March 2008 and March 2009. Age-specific seroprevalence was also determined. Some risk factors like level of education, type of residence, job, numbers of family members, and access to treated water were also evaluated in these participants.

Results: From 1050 subjects studied, 927 (88.2%) had ant-HAV antibody; 123 (11.8%) were antibody negative. Among subjects aged < 20 years, the anti-HAV seroprevalence was the lowest (79.3%) followed by subjects aged 20-30 years (91.3%) and those > 30 years (99%) (p = 0.01). 85.1% of studied individuals in urban areas had anti-HAV IgG while 95.9% of subjects in rural regions were anti-HAV positive (p = 0.001). The seroprevalence of HAV antibody was significantly associated with number of family members (p = 0.001).

Conclusion: HAV is highly prevalent in our region especially in rural areas. It is better to vaccinate the children for HAV by the time they receive HBV vaccine or when they are five years.

Citing Articles

Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among the fulminant hepatitis A virus infection patients.

Ejtehadi F, Serpoosh M, Shahramian I, Aminlari L, Niknam R, Sivandzadeh G Caspian J Intern Med. 2024; 15(3):451-458.

PMID: 39011425 PMC: 11246672. DOI: 10.22088/cjim.15.3.451.

The Seroprevalence of Hepatitis A in Patients with Positive Human Immunodeficiency Virus.

Omidifar N, Bagheri Lankarani K, Aghazadeh Ghadim M, Khoshdel N, Joulaei H, Keshani P Middle East J Dig Dis. 2023; 15(3):196-202.

PMID: 38023458 PMC: 10660319. DOI: 10.34172/mejdd.2023.344.

Hepatitis A in the Eastern Mediterranean Region: a comprehensive review.

Badur S, Ozturk S, AbdelGhany M, Khalaf M, Lagoubi Y, Ozudogru O Hum Vaccin Immunother. 2022; 18(5):2073146.

PMID: 35617508 PMC: 9621081. DOI: 10.1080/21645515.2022.2073146.

Prevalence of HAV Ab, HEV (IgG), HSV2 IgG, and Syphilis Among Sheltered Homeless Adults in Tehran, 2012.

Jahanbakhsh F, Bagheri Amiri F, Sedaghat A, Fahimfar N, Mostafavi E Int J Health Policy Manag. 2018; 7(3):225-230.

PMID: 29524951 PMC: 5890067. DOI: 10.15171/ijhpm.2017.74.

Prevalence of G6PD deficiency in Children with Hepatitis A.

Miri-Aliabad G, Khajeh A, Shahraki T Int J Hematol Oncol Stem Cell Res. 2017; 11(2):92-95.

PMID: 28875002 PMC: 5575731.

References

Saha S, Saha S, Shakur S, Hanif M, Habib M, Datta S . Community-based cross-sectional seroprevalence study of hepatitis A in Bangladesh. World J Gastroenterol. 2009; 15(39):4932-7. PMC: 2764972. DOI: 10.3748/wjg.15.4932. View

Dhawan P, Shah S, Alvares J, Kher A, Shankaran , Kandoth P . Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine. Indian J Gastroenterol. 1998; 17(1):16-8. View

Kunasol P, Cooksley G, CHAN V, Isahak I, John J, Loleka S . Hepatitis A virus: declining seroprevalence in children and adolescents in Southeast Asia. Southeast Asian J Trop Med Public Health. 1999; 29(2):255-62. View

Roushan M, Bijani A, Sagheb R, Jazayeri O . Prevalence of hepatitis A IgG in individuals with chronic hepatitis B infection in Babol. East Mediterr Health J. 2008; 13(5):1108-13. DOI: 10.26719/2007.13.5.1108. View

Sofian M, Aghakhani A, Farazi A, Banifazl M, Etemadi G, Azad-Armaki S . Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis. 2010; 8(3):176-9. DOI: 10.1016/j.tmaid.2010.02.004. View

Lee D, Cho Y, Park Y, Hwang J, Kim J, Kim N . Hepatitis a in Korea: epidemiological shift and call for vaccine strategy. Intervirology. 2008; 51(2):70-4. DOI: 10.1159/000127428. View

Abdolvahab M, Behnaz K, Sima B, M T . Hepatitis a in young adults in the golestan province, northeast of iran. J Glob Infect Dis. 2010; 2(2):198-9. PMC: 2889666. DOI: 10.4103/0974-777X.62862. View

Melnick J . History and epidemiology of hepatitis A virus. J Infect Dis. 1995; 171 Suppl 1:S2-8. DOI: 10.1093/infdis/171.supplement_1.s2. View

Mehr A, Ehsani Ardakani M, Hedayati M, Shahraz S, Mehr E, Zali M . Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 2004; 19(3):275-8. DOI: 10.1023/b:ejep.0000020345.37091.cd. View

10.

Jacobsen K, Koopman J . Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2005; 132(6):1005-22. PMC: 2870191. DOI: 10.1017/s0950268804002857. View

11.

Shapiro C, Margolis H . Worldwide epidemiology of hepatitis A virus infection. J Hepatol. 1993; 18 Suppl 2:S11-4. DOI: 10.1016/s0168-8278(05)80371-x. View

12.

Murhekar M, Sehgal S, Murhekar K, Padbhidri S, Chitambar S, Arankalle V . Changing scenario of hepatitis A virus and hepatitis E virus exposure among the primitive tribes of Andaman and Nicobar Islands, India over the 10-year period 1989-99. J Viral Hepat. 2002; 9(4):315-21. DOI: 10.1046/j.1365-2893.2002.00355.x. View

13.

Koff R . Hepatitis A. Lancet. 1998; 351(9116):1643-9. DOI: 10.1016/S0140-6736(98)01304-X. View

14.

Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S . Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010; 13(2):99-104. View

15.

Das K, Jain A, Gupta S, Kapoor S, Gupta R, Chakravorty A . The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol. 2000; 16(6):507-10. DOI: 10.1023/a:1007628021661. View